Navigation Links
Immunology in Medical Technology

Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings

CAMBRIDGE, Mass., June 9 /PRNewswire/ -- Peptimmune, Inc., a privately held biotechnology company, presented early clinical results from its PI-2301 peptide copolymer program at both the 17th Annual ENS meeting in Nice, France and at FOCIS 2008 in Boston, MA. The Company presented data from it...

Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference

Chimeric Peptide Vaccine Aims to Use Memory Imprint to Yield a Strong and Highly Specific Immune Response NEW YORK, Aug. 20 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) a biopharmaceutical company focused on development of disease-modifyi...

Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology

Data Supports Use of HIV-specific T cell Precursors with High Proliferative Capacity (PHPC) Marker to Predict Reduction of Viral Load MCLEAN, Va., and BUDAPEST, Hungary, April 21 /PRNewswire/ -- Genetic Immunity(R), a US/Hungarian clinical-stage company focused on patented nanomedicines fo...

MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases

- Preclinical Data Support Rationale for Targeting Pro-Inflammatory Protein - GAITHERSBURG, Md., April 18, 2007 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced the publication of preclinical study data demonstrating a role for high mobility group box protein-1 (HMGB1), a nuclear DNA-bind...

Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology

LEXINGTON, Mass.--(BUSINESS WIRE)--Apr 18, 2007 - Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced that new preclinical research demonstrating a role in chronic inflammatory autoimmune disease for High Mobility Group Box-1 protein (HMGB1), a pro-inflammatory mediator and nuclear DNA-bindi...

Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology

MILWAUKEE, July 11, 2007 /PRNewswire/ -- A new study suggests strong variation in the occurrence of anaphylaxis between the northern and southern U.S. Anaphylaxis is a severe allergic reaction that can be fatal without treatment with epinephrine. The striking north-south differences in EpiPen pres...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

...t of new information, future events or otherwise. (i) Wucherpfennig KW, Weiner HL, Hafler DA. T-cell recognition of myelin basic protein. immunology Today, 1991; 12: 277-282. (ii) Ransohoff, R.M. Natalizumab for Multiple Sclerosis. New England Journal of Medicine, 2007 Jun; 356; 25: 2622. (ii...

Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints

...t Phase III study and Associate Professor of Medicine, Division of Clinical immunology and Rheumatology, and Director, University Clinical Research Center, Unive...lization of innovative medicines with a focus on central nervous system and immunology disorders. Employing around 10,000 people in over 40 countries, UCB achieve...

CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas

...ex virus (HSV) glycoprotein to make a vaccine that induces a defined immune response. Last month Dr. Kenneth S. Rosenthal, Professor of Microbiology, immunology and Biochemistry at Northeastern Ohio Universities Colleges of Medicine and Pharmacy and colleagues showed that CEL-SCI's L.E.A.P.S. vaccines can acti...

Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults

... company dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing approx. 10 000 people in over 40 countries, UCB achieved revenues of 3.6 billion Euro in 2008. UCB is listed on Euronext Brussels...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

... company dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing approximately 10,000 people in over 40 countries, UCB generated revenue of EUR 3.6 billion in 2008. UCB is listed on Euronext Bru...

Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program

...m person-to-person. Robert Garry, Ph.D., Professor of Microbiology and immunology at the Tulane University School of Medicine and Principle Investigator of...der in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases, bone and joint disorders. Corgenix diagnostic...

New Study Shows Probiotic Strain Effective in Boosting Immune Response to Flu Virus

...the current study. Dr. Gary Huffnagle, a professor of microbiology and immunology at the University of Michigan , who has reviewed the study's findings, sai...r. Ken Alibek, M.D., Ph.D., Sc.D., an infectious disease, microbiology, and immunology expert who has studied Bacillus coagulans extensively, believes that the ...

Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma

...has strong preclinical efficacy with PCI-32765 in these disease models," said Dr. Mark Genovese, Professor of Medicine and Co-Chief of the Division of immunology and Rheumatology at Stanford University Medical Center and member of Pharmacyclics' Scientific Advisory Board. "Despite recent success with b...

Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09

...nworks.com . About Corgenix Medical Corporation Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for aspirin effect. Corgenix diagnostic pro...

Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions

...nologist with broad training in basic and clinical immunology and a vocation for clinical development in the fie...He was a Director of Clinical Discovery, Oncology/ immunology at Bristol-Myers Squibb where he worked on Crohn's...liac disease. He completed a residency in Clinical immunology at Ramon y Cajal Hospital, Madrid where he was ele...

Changing Paradigms in Hereditary Angioedema: A Focus on Prompt Diagnosis and New Therapies

..., and pharmacists. The faculty for these lectures comprises experts in immunology and HAE from leading medical institutions. The chairperson is Bruce L. Zuraw, MD, Professor of Medicine and Chief of the Section of Allergy and immunology at the University of California School of Medicine in San Diego, CA. ...

New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits

...S, N.J., March 14 /PRNewswire-FirstCall/ -- Results of a new study presented at the 2009 Annual Meeting of the American Academy of Asthma, Allergy and immunology (AAAAI) show dramatic reductions in emergency room (ER) visits and hospitalizations for asthma patients taking cholesterol-lowering statins in additio...

IBT Laboratories to Launch New Pneumococcal Antibody Avidity Test at AAAAI Meeting, Booth 729

...and biomedical-research laboratory specializing in immunology and allergy assays, will launch a new diagnostic a...ng of the American Academy of Allergy, Asthma, and immunology (AAAAI), which opens tomorrow in Washington, DC. T..." IBT offers the widest range of allergy and immunology tests of any laboratory worldwide. The company has...

DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology

...musculoskeletal diseases and at providing general pain relief. MediVas will focus its development efforts on nanoparticle based therapies in oncology, immunology and on the delivery of nucleic acids. " Through this deal we bring in the first biodegradable polymer into DSM's Biomedical portfolio, which sig...

Scientists Unmask Genetic Markers Associated With Psoriasis

... or too many Th2 cells in relation to other types of T cells may result in disease, including psoriasis. This new research, together with recent immunology work by Elder and colleagues, links four psoriasis loci (IL12B, IL23A, IL23R and IL4/IL13) together in a common functional pathway. Implication...

New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures

...industry dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing approximately 12,000 people in more than 40 countries, UCB achieved revenue of 3.6 billion euro in 2007. UCB is listed on NYSE Eu...

Cambridge Laboratories Announces Approval of Tetrabenazine in Spain

...industry dedicated to the research, development and commercialisation of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing around 12 000 people in over 40 countries, UCB achieved revenue of 3.6 billion Euro in 2007. UCB is listed on Euronext Brussels (...

IBT Laboratories Expands its Menu of Tests for Immune Deficiency

...and biomedical-research laboratory specializing in immunology and allergy assays, announced that it has launched...ting of the American College of Allergy Asthma and immunology in Seattle. According to IBT Founder and...sicians with much greater insight into a patient's immunology profile than was possible before. "We rely on our ...

Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia

... patients' quality of life," said I. Jon Russell, M.D., Ph.D., the study's lead investigator and Associate Professor of Medicine, Division of Clinical immunology and Rheumatology, and Director, University Clinical Research Center, University of Texas Health Science Center at San Antonio. The 14-week s...

ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema

...treated for laryngeal attacks required hospitalization or intubation. The findings were presented today at the American College of Allergy, Asthma and immunology (ACAAI) 2008 Annual Meeting in Seattle, WA. "The open label extension study findings indicated Cinryze was well tolerated in this study, and success...

Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease

...ht loss, pale sores inside the mouth, tooth discoloration or loss of enamel, depression, chronic diarrhea or constipation, gas and abdominal pain. The immunology and nutritional abnormalities in celiac disease can potentially result in long- term complications such as osteoporosis, refractory sprue, small intes...

Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

...o treat children aged six through 11 planned SEATTLE, Nov. 8, 2008 /PRNewswire/ -- Data presented today at the American College of Allergy, Asthma & immunology (ACAAI) show that Xolair(R) (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or se...

Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference

...ous for the relief of symptoms in patients with symptomatic knee osteoarthritis," said Dr. Marc C. Hochberg, Head, Division of Rheumatology & Clinical immunology at the University of Maryland School of Medicine. "Furthermore, it had similar efficacy to orally administered diclofenac with fewer gastrointestinal,...

CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years

...industry dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing around 12 000 people in over 40 countries, UCB achieved revenue of 3.6 billion euro in 2007. UCB is listed on Euronext Brussels (...

Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting

...pale sores inside the mouth, tooth discoloration or loss of enamel, depression, chronic diarrhea or constipation, and abdominal pain and bloating. The immunology and nutritional abnormalities in celiac disease can potentially result in long-term complications such as osteoporosis, refractory sprue, small intest...

CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients

...industry dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing around 12 000 people in over 40 countries, UCB achieved revenue of 3.6 billion euro in 2007. UCB is listed on Euronext Brussels (...

Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications

...JPMorgan Securities, and has been an analyst in the sector since 2000. Dr. Smith holds a Ph.D. from the University of Oxford with a focus in Virology, immunology and Molecular Biology and has published research in medical journals including Virology. "We are pleased to welcome Richard to Pharmasset," said Sch...

CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients

...industry dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing around 12,000 people in over 40 countries, UCB achieved revenue of 3.6 billion euro in 2007. UCB is listed on Euronext Brussels (...

DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers

...om/cgi-bin/prnh/20071106/KARMANOSCANCERINSTITUTELO GO) Wei-Zen Wei, Ph.D., professor at the Barbara Ann Karmanos Cancer Institute and Department of immunology and Microbiology, Wayne State University School of Medicine, together with a team of researchers have been working on a series of cancer-fighting vacc...

Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis

...erman, Senior Vice President of Research, Cellular immunology of CEL-SCI, indicate that CEL-SCI's rheumatoid art... for the first 14 days (for the histopathology and immunology studies) or every other day over the entire study period of 28 days (for the immunology studies only). Dr. Zimmerman reported previously...

Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program

...e and effective vaccines quickly and reliably," said Robert B. Belshe, M.D., Dianna and J. Joseph Adorjan Endowed Professor of Infectious Diseases and immunology at the Saint Louis University School of Medicine, who served on the Data and Safety Monitoring Board for the study. "Two doses of this novel vaccine -...

Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines

...consistent virologic suppression in patients new to antiretroviral therapy," said Scott Brun, M.D., divisional vice president, Infectious Diseases and immunology Development, Global Pharmaceutical Research and Development, Abbott. "Additionally, the Kaletra tablet formulation is a convenient HIV treatment optio...

Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma

...k, in collagen induced arthritis, an established animal model for rheumatoid arthritis (RA). The data were presented during the Federation of Clinical immunology Societies (FOCIS) meeting being held this week in Boston, MA. Researchers examined the impact of treatment with PCI-32765 on mouse models of rheumat...

FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture

...evention of additional fractures after a hip fracture(2)," said Kenneth G. Saag, MD, MSc, Professor of Medicine and Epidemiology, Division of Clinical immunology and Rheumatology, University of Alabama at Birmingham. "In the first large scale clinical trial of its kind, these data support an efficacious therape...
Other Tags
(Date:7/10/2014)... , June 27, 2014  The American Academy ... Institute of Standards and Technology (NIST) and the ... academic research and forensic science expert members to ... is an element of the NIST,s Organization of ... among the first appointments made to the new ...
(Date:7/10/2014)... 30, 2014  Aware, Inc. (NASDAQ: AWRE ... previously announced on June 26, 2014 that its Board ... $1.75 per share, or approximately $40 million in total.  ... 2014 and a payment date of July 24, 2014.  ... had set an ex-dividend date for this special cash ...
(Date:7/10/2014)... 2014  Unisys Corporation,s (NYSE: UIS ) subsidiary ... today announced that it has been selected by the Dutch ... new Basic Provision Biometrics solution for penitentiaries across ... contract with a solution based on its open standards-based ... the contract is up to seven years, with the new ...
Breaking Biology News(10 mins):Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3
(Date:7/14/2014)... Kathleen Doheny HealthDay Reporter ... spouse may be linked to multiple health issues, but dementia ... For certain seniors, widowhood may even delay dementia, the researchers ... losing the spouse was associated with a later age of ... study researcher Dr. Bryan Woodruff. Woodruff, an assistant ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 ... celebrating its Grand Opening on Monday, July 14th, ... 06830. The celebration will last all week through ... new patients. Everyone is welcomed to attend. The ... who provides physician-administered skincare, anti-aging, weight loss services, ...
(Date:7/14/2014)... July 14, 2014 Many people are ... undergo plastic surgery to reduce a “double chin.” ... eliminates the need to go under the knife. Jawflex ... the jaw muscles, therefore tightening the skin in that ... , Jawflex is used for facial exercise, double chin ...
(Date:7/14/2014)... Tysons, VA (PRWEB) July 14, 2014 ... been a local icon to the Tysons Corner skyline ... Corner becoming its own municipality, known simply as “Tysons”, ... Sheraton Tysons Hotel. In addition to Tysons becoming ... Stations located in the heart of Tysons brings an ...
(Date:7/14/2014)... Kenn Renner recently released a new video describing ... describe the business on Austin Real Estate Investments . ... Kenn Renner – is internationally recognized for his combined expertise ... , Investing in real estate is a great way for ... their career, while others like to do it as a ...
Breaking Medicine News(10 mins):Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 3Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 2Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 3Health News:Jawflex | Double Chin Exercise for Double Chin Reduction 2Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 2Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 3Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 4
Other Contents